Answers are grounded in this paper and cite their sources.
Prostate cancer is one of the most common types of cancers to affect men worldwide. The cancer area must be precisely segmented from the magnetic resonance imaging (MRI) scan to enhance the efficiency of treatments and the patient’s chances of overcoming prostate cancer (PC). However, identifying tumor locations within the prostate gland poses significant challenges due to variations in prostate shapes among patients, indistinct boundary delineation, and the utilization of multiple MRI modes. To solve these issues, a novel 3D U-Net Deep Autoencoder approach is used to predict and detect prostate tumor locations within MRI datasets. The models encoder block is exploited for feature extraction from input images and expeditious Region Of Interest selection through AutoEncoder training. Furthermore, the Block-Matching and 3D Filtering and histogram equalization techniques are employed to enhance grayscale intensity values at specific ROI boundaries in PC images. Moreover, the implementation of k-fold cross-validation ensures a robust evaluation of the training model. The proposed methodology has been validated using the Medical Segmentation Decathlon Prostate1 dataset for detecting PC Segmentation. To validate the proposed approach several performance evaluation metrics are used, namely, accuracy, Jaccard Similarity Coefficient, Mean Square Error, Dice Similarity Coefficient, Structural Similarity Index Measure, Hausdorff Distance, Peak Signal to Noise Ratio, Average Boundary Distance, and Intersection Over Union to evaluate the experimental outcomes. The proposed scheme outperforms performance compared with state-of-the-art segmentation models when applied to the MRI prostate cancer dataset.
No takes yet. Share an insight, caveat, or question.
Murmu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: